NCT06939907View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

July 31, 2027

Conditions
Lower Gastrointestinal BleedingDiverticular Bleeding
Interventions
DEVICE

Nexpowder™

Nexpowder™ hemostatic powder

Trial Locations (6)

Unknown

Chungbuk National University Hospital, Cheongju-si

Chungnam National University Hospital, Daejeon

Chosun University Hospital, Gwangju

Sejong Chungnam National University Hospital, Sejong

Kangdong Kyunghee University Hospital, Seoul

Yangsan Busan National University Hospital, Yangsan

All Listed Sponsors
lead

Next Biomedical Co., Ltd.

INDUSTRY